找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Endocrine Therapy of Breast Cancer IV; A. Goldhirsch Conference proceedings 1990 Springer-Verlag Berlin Heidelberg 1990 Hormonrezeptoren.O

[复制链接]
查看: 11939|回复: 47
发表于 2025-3-21 16:13:30 | 显示全部楼层 |阅读模式
书目名称Endocrine Therapy of Breast Cancer IV
编辑A. Goldhirsch
视频video
丛书名称ESO Monographs
图书封面Titlebook: Endocrine Therapy of Breast Cancer IV;  A. Goldhirsch Conference proceedings 1990 Springer-Verlag Berlin Heidelberg 1990 Hormonrezeptoren.O
描述The European School of Oncology came into existence to respond to a need for informa­ tion, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was. considered necessary. Firstly, the teaching of oncology requires a rigorously multidisciplinary approach which is difficult for the Univer­ sities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis and treatment of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and the seminars on new techniques (laser, monoclonal antibodies, imaging techniques etc.) or on the principal therapeutic controversies (conservative or mutilating surgery, primary or adjuvant chemotherapy, radiotherapy alone or integrated), it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the University and Industry and between these two and daily medical practice. One of the more recent initiatives of ESO has
出版日期Conference proceedings 1990
关键词Hormonrezeptoren; Ovarsuppression; breast cancer; cancer; carcinogenesis; cell; chemotherapy; genetics; horm
版次1
doihttps://doi.org/10.1007/978-3-642-75948-2
isbn_softcover978-3-642-75950-5
isbn_ebook978-3-642-75948-2
copyrightSpringer-Verlag Berlin Heidelberg 1990
The information of publication is updating

书目名称Endocrine Therapy of Breast Cancer IV影响因子(影响力)




书目名称Endocrine Therapy of Breast Cancer IV影响因子(影响力)学科排名




书目名称Endocrine Therapy of Breast Cancer IV网络公开度




书目名称Endocrine Therapy of Breast Cancer IV网络公开度学科排名




书目名称Endocrine Therapy of Breast Cancer IV被引频次




书目名称Endocrine Therapy of Breast Cancer IV被引频次学科排名




书目名称Endocrine Therapy of Breast Cancer IV年度引用




书目名称Endocrine Therapy of Breast Cancer IV年度引用学科排名




书目名称Endocrine Therapy of Breast Cancer IV读者反馈




书目名称Endocrine Therapy of Breast Cancer IV读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:32:28 | 显示全部楼层
osis and treatment of cancer. There are two main reasons why such an initiative was. considered necessary. Firstly, the teaching of oncology requires a rigorously multidisciplinary approach which is difficult for the Univer­ sities to put into practice since their system is mainly disciplinary orien
发表于 2025-3-22 04:24:07 | 显示全部楼层
发表于 2025-3-22 07:44:15 | 显示全部楼层
Reproductive Diversity of Plants A remarkable feature of treatment with tamoxifen is the low incidence of side effects [1,3]. These clinical observations and the large body of evidence from the laboratory [6,7] have focussed clinical attention on long-term, or indefinite (treatment until relapse), adjuvant tamoxifen therapy [5,8–10].
发表于 2025-3-22 12:40:48 | 显示全部楼层
Floral Morphology and Sexuality,ls indicate that it is as effective as older treatments, for example, oe- strogens [2], but has fewer side effects. In premenopausal women, treatment with tamoxifen is equivalent in effectiveness to oophorectomy [3].
发表于 2025-3-22 13:09:59 | 显示全部楼层
Role of Oestrogen and Progestin in Human Mammary Carcinogenesis,cally-derived risk factors such as the protective effect of ovariectomy and increased risk of breast cancer in young women given diethylstilboestrol to prevent abortion [1,2]; and (c) the mitogenic effects of oestrogens on established breast cancer cell lines [5,6] and efficacy of antioestrogens in treating established breast cancer [7].
发表于 2025-3-22 19:28:20 | 显示全部楼层
发表于 2025-3-22 22:16:02 | 显示全部楼层
Tamoxifen as an Agonist for Metastatic Breast Cancer,ls indicate that it is as effective as older treatments, for example, oe- strogens [2], but has fewer side effects. In premenopausal women, treatment with tamoxifen is equivalent in effectiveness to oophorectomy [3].
发表于 2025-3-23 01:26:19 | 显示全部楼层
发表于 2025-3-23 06:41:27 | 显示全部楼层
https://doi.org/10.1007/978-1-4612-2866-0DNA ploidy, oncogenes, growth factor receptors, and some glycoproteins) are used for making therapeutic decisions [2]. At present, more than 60 prognostic parameters have been reported and can be classified into 4 main groups: patient characteristics, blood parameters, tumour characteristics and response to therapy (Table 2).
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-15 05:52
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表